Evaluating Thailand’s malaria reactive surveillance and response strategies for malaria elimination: a mixed-method study
October 30, 2025
Background Thailand aims to eliminate malaria in all provinces by 2030, where 37 out of 77 provinces have been verified…
A malaria seasonality dataset for sub-Saharan Africa
October 28, 2025
Malaria imposes a significant global health burden and remains a major cause of child mortality in sub-Saharan Africa. In many…
Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens
October 23, 2025
Background Knowledge of the genetic diversity of Plasmodium vivax antigen vaccine candidates can offer valuable insights into antigens targeted by host immunity…
Tfh2 and a subset of Tfh1 cells associate with antibody-mediated immunity to malaria
October 21, 2025
High-affinity antibody production depends on CD4+ T follicular helper (Tfh) cells. In humans, peripheral blood Tfh cells are heterogenous, as…
Age is an intrinsic driver of inflammatory responses to malaria
September 30, 2025
Age is a critical factor in immune responses to infection. In malaria, severe disease risk increases with age in non-immune…
Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia
September 30, 2025
Background Plasmodium vivax malaria remains a significant public health concern in the Asia Pacific, the Americas, and the Horn of Africa….
Sharing research results with participants: more than good manners
September 8, 2025
Most research participants want to know the results of the studies they contribute to, yet many never hear back. A…
Strengthening country ownership of national antimalarial policymaking: insights from Laos, Pakistan and the Solomon Islands
September 2, 2025
Background The concept of “ownership” in global health policymaking broadly assumes that external donors and advisors expect recipient countries to…
Effectiveness and Safety of High Dose Primaquine and Tafenoquine in Plasmodium vivax Patients (EFFORT) – A Multi-Centre, Open Label, Superiority Randomised Controlled Trial
August 30, 2025
Background: Shorter courses of primaquine and single dose tafenoquine have potential to improve effectiveness in preventing recurrent Plasmodium vivax infection,…
Current global practice and implications for future research on disseminating health research results to study participants: A systematic review
August 14, 2025
Background Disseminating research findings to study participants is a critical component of clinical research. There is evidence that dissemination strengthens…